Amy Bates, PA
Physician Assistant · York, PANPI 1609196443
Payments from drug & device makers
Across 232 payments — averaging $17.76 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AbbVie$621
- Novo Nordisk$620
- Lilly USA, LLC$540
- Pfizer$371
- AstraZeneca$313
- Salix Pharmaceuticals, A Division Of Bausch Health US, LLC$259
- plus $1K from 24 others
What the payments were for
- Food & beverage$4,120100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AbbVie | 38 | $621 |
| Novo Nordisk | 36 | $620 |
| Lilly USA, LLC | 30 | $540 |
| Pfizer | 24 | $371 |
| AstraZeneca | 18 | $313 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 15 | $259 |
| GSK | 9 | $151 |
| E.r. Squibb & Sons, L.L.C. | 7 | $141 |
| Exact Sciences | 5 | $114 |
| Abbott | 5 | $98 |
| Astellas Pharma US Inc | 3 | $82 |
| Lundbeck LLC | 4 | $77 |
| Phathom Pharmaceuticals, Inc. | 3 | $72 |
| Idorsia Pharmaceuticals US Inc | 4 | $70 |
| Boehringer Ingelheim | 4 | $60 |
| Merck | 3 | $60 |
| Otsuka America Pharmaceutical, Inc. | 3 | $51 |
| Amgen | 3 | $48 |
| Dexcom, Inc. | 3 | $48 |
| Biohaven Pharmaceuticals, Inc. | 2 | $47 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 2 | $42 |
| Supernus Pharmaceuticals, Inc. | 2 | $42 |
| Verona Pharma, Inc. | 1 | $33 |
| Bayer | 2 | $33 |
| Cequr Corporation | 1 | $28 |
| Almatica Pharma LLC | 1 | $27 |
| Axsome Therapeutics, Inc. | 1 | $23 |
| Genentech USA, Inc. | 1 | $22 |
| Philips North America LLC | 1 | $17 |
| Xeris Pharmaceuticals, Inc. | 1 | $13 |
How this compares
$4,120 in reported general payments places this provider in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| EliquisApixaban | 141 | $173,016 |
| JardianceEmpagliflozin | 42 | $57,096 |
| OzempicSemaglutide | 19 | $29,874 |
| XareltoRivaroxaban | 15 | $19,989 |
| JanuviaSitagliptin Phosphate | 12 | $19,102 |
| TrulicityDulaglutide | 12 | $18,265 |
| Basaglar Kwikpen U-100Insulin Glargine,hum.Rec.Anlog | 25 | $12,751 |
| Breo ElliptaFluticasone/Vilanterol | 24 | $10,959 |
| InvokanaCanagliflozin | 15 | $10,742 |
| Toujeo Max SolostarInsulin Glargine,hum.Rec.Anlog | 12 | $9,573 |
| Trelegy ElliptaFluticasone/Umeclidin/Vilanter | 11 | $7,223 |
| Tresiba Flextouch U-100Insulin Degludec | 15 | $6,260 |
| Metoprolol Succinate | 291 | $5,014 |
| Atorvastatin Calcium | 591 | $4,940 |
| OxycontinOxycodone Hcl | 11 | $4,835 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| PfizerEliquis | $371 | $173,016141 claims |
| Boehringer IngelheimJardiance | $60 | $57,09642 claims |
| Novo NordiskOzempic | $620 | $29,87419 claims |
| MerckJanuvia | $60 | $19,10212 claims |
| Lilly USA, LLCTrulicity | $540 | $18,26512 claims |
| GSKBreo Ellipta, Trelegy Ellipta | $151 | $18,18235 claims |
| AbbVieSynthroid | $621 | $3,56042 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 90th percentile of 6,643 physician assistant providers in Pennsylvania.
Other physician assistant in York
- Christina PattersonYork$60K
- Erin CrownState College$1.5M
- Tricia BootsCranberry Twp$313K
- Melissa FerrariPhiladelphia$223K
- Jason OberdickWexford$206K
- Justine RobertsMurrysville$173K
- Allison BoydErie$163K
- Joshua TrbovichWashington$144K
- Daniel TelegaErie$124K
- Alvin KingcadePhiladelphia$101K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.